Seroprevalence and risk factors for hepatitis E virus infection in the Romanian adult population: a cross-sectional study in a tertiary hospital

1. Dalton HR, Kamar N, Baylis SA, Moradpour D, Wedemeyer H, Negro F. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018;68:1256–71. DOI: 10.1016/j.jhep.2018.03.00510.1016/j.jhep.2018.03.005Open DOISearch in Google Scholar

2. Nimgaonkar I, Ding Q, Schwartz RE, Ploss A. Hepatitis E virus: advances and challenges. Nature Reviews Gastroenterology & Hepatology. 2018;15:96-110. DOI: 10.1038/nrgastro.2017.15010.1038/nrgastro.2017.150Open DOISearch in Google Scholar

3. Hepatitis E: a neglected virus. Editorial. The Lancet Gastroenterology & Hepatology. 2016;1(4):261. DOI: 10.1016/S2468-1253(16)30152-210.1016/S2468-1253(16)30152-2Open DOISearch in Google Scholar

4. Purdy MA, Harrison TJ, Jameel S, Meng XJ, Okamoto H, Van der Poel WHM, et al. ICTV virus taxonomy profile: hepeviridae. J Gen Virol. 2017;98:2645–6. DOI: 10.1099/jgv.0.00094010.1099/jgv.0.000940571825429022866Open DOISearch in Google Scholar

5. World Health Organization. Hepatitis E vaccine: WHO position paper, May 2015 – Recommendations. Vaccine. 2016;34(3):304-5. DOI: 10.1016/j.vaccine.2015.07.05610.1016/j.vaccine.2015.07.05626232546Open DOISearch in Google Scholar

6. Debing Y, Moradpour D, Neyts J, Gouttenoire J. Update on hepatitis E virology: Implications for clinical practice. J Hepatol. 2016;65(1):200-12. DOI: 10.1016/j.jhep.2016.02.04510.1016/j.jhep.2016.02.04526966047Open DOISearch in Google Scholar

7. Fischer C, Hofmann M, Danzer M, Hofer K, Kaar J, Gabriel C. Seroprevalence and Incidence of hepatitis E in Blood Donors in Upper Austria. PLoS ONE. 2015;10(3):e0119576. DOI: 10.1371/journal.pone.011957610.1371/journal.pone.0119576435362525751574Search in Google Scholar

8. Hartl J, Otto B, Madden RG, Webb G, Woolson KL, Kriston L, et al. Hepatitis E Seroprevalence in Europe: A Meta-Analysis. Viruses. 2016;8(8):211. DOI: 10.3390/v808021110.3390/v8080211499757327509518Search in Google Scholar

9. Slot E, Hogema B M, Riezebos-Brilman A, Kok T M, Molier M, Zaaijer H L. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill. 2013;18(31). pii: 20550. DOI: 10.2807/1560-7917. ES2013.18.31.2055010.2807/1560-7917.ES2013.18.31.2055023929229Open DOISearch in Google Scholar

10. Adlhoch C, Avellon A, Baylis SA, Ciccaglione AR, Couturier E, de Sousa R, et al. Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15. J Clin Virol. 2016;82:9–16. DOI: 10.1016/j.jcv.2016.06.01010.1016/j.jcv.2016.06.01027393938Search in Google Scholar

11. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384:1766–73; DOI: 10.1016/S0140-6736(14)61034-510.1016/S0140-6736(14)61034-5Open DOISearch in Google Scholar

12. Kamar N, Wang W, Dalton HR, Pan Q. Direct-acting antiviral therapy for hepatitis E virus? The Lancet Gastroenterology & Hepatology. 2017;2(3):154–5; DOI: 10.1016/S2468-1253(16)30242-410.1016/S2468-1253(16)30242-4Open DOISearch in Google Scholar

13. World Health Organization. Hepatitis E vaccine: WHO position paper (Note de synthèse: position de l’OMS à propos du vaccine contre l’hépatite E). Weekly epidemiological record (Relevé épidémiologique hebdomadaire) 2015;90:185–200.Search in Google Scholar

14. Nascimento MSJ, Pereira SS, Teixeira J, Abreu-Silva J, Oliveira RMS, Myrmel M et al. A nationwide serosurvey of hepatitis E virus antibodies in the general population of Portugal. Eur J Public Health. 2018;28(4):720-4. DOI: 10.1093/eurpub/ckx21310.1093/eurpub/ckx21329237007Open DOISearch in Google Scholar

15. Aggarwal R, Gandhi S. The Global Prevalence of Hepatitis E Virus Infection and Susceptibility: A Systematic Review. Immunization, Vaccines and Biologicals. 2010; WHO/IVB/10.14.Search in Google Scholar

16. Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis. 2011;17:2309–12. DOI: 10.3201/eid1712.11037110.3201/eid1712.110371331120022172156Open DOISearch in Google Scholar

17. Muller B, Koch H, Pichl L. PCR-Screening of blood donations for hepatitis E with the cobas HEV test performed on the new Roche cobas 8800 platform in minipools of 6. Transfus Med Hemother. 2015;42:1–66.Search in Google Scholar

18. Zaaijer HL. No artifact, hepatitis E is emerging. Hepatology. 2015;62:654. DOI: 10.1002/hep.2761110.1002/hep.2761125418372Open DOISearch in Google Scholar

19. Thom K, Gilhooly P, McGowan K, Malloy K, Jarvis LM, Crossan C, et al. HEV in Scotland: evidence of recent increase in viral circulation in humans. Euro Surveill. 2018;23(12). DOI: 10.2807/1560-7917. ES.2018.23.12.17-0017410.2807/1560-7917.ES.2018.23.12.17-00174620525929589577Open DOISearch in Google Scholar

20. Domanović D, Tedder R, Blümel J, Zaaijer H, Gallian P, Niederhauser C, et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017;22(16):30514. DOI: 10.2807/1560-7917.ES.2017.22.16.3051410.2807/1560-7917.ES.2017.22.16.30514540448028449730Open DOISearch in Google Scholar

21. Dreier J, Knabbe C, Vollmer T. Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose. Frontiers in Medicine. 2018;5:5. DOI: 10.3389/fmed.2018.0000510.3389/fmed.2018.00005579928729450199Open DOISearch in Google Scholar

22. Spada E, Pupella S, Pisani G, Bruni R, Chionne P, Madonna E, et al. A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors. Blood Transfusion. 2018;16(5):413-21.Search in Google Scholar